Medical Information
Afrique
 

This medical information website is intended only for healthcare professionals in Africa. This information is not intended as medical advice. Responsibility for patient care resides with the healthcare professional on the basis of his or her professional license, experience and knowledge of the patient.

Please choose the category that best describes you.

Congress Materials

The information on this page pertains to selected congresses, congress materials, therapeutic and disease areas. It is not intended to serve as a comprehensive overview of all congresses, congress materials, therapeutic and disease areas.
Congress materials may include information for which the product is not approved and/or inconsistent with the product uses described in the Prescribing Information. Pfizer does not suggest or recommend the use of Pfizer Products in any manner other than as described in the Prescribing Information.

Poster
Marianna Bruno, Radhika Nair, Casey Reed, Alexander Schepart, Richard Sheer, Edward W. Casey, Jeff D. Simmons March 29, 2022 AMCP 2022 Transthyretin Amyloidosis (ATTR)
Poster
Bhambri R, Colavecchia C, Bruno M, Chen Y, Alvir J, Roy A, Kemner J, Crowley A, Benjumea D, Gilstrap L April 2, 2022 ACC 2022 Transthyretin Amyloidosis (ATTR)
Poster
Sperry BW, Hanna MA, Maurer MS, Nativi-Nicolau J, Floden L, Stewart M, Wyrwich K, Barsdorf A, Kapadia H, Spertus JA April 2, 2022 ACC 2022 Transthyretin Amyloidosis (ATTR)
Poster
Elliott P, Gundapaneni B, Sultan MB, Ines M, Garcia-Pavia P May 21, 2022 HFA 2022 Transthyretin Amyloidosis (ATTR)
Oral Presentation
Garcia-Pavia P, Piriou N, Barriales-Villa R, Cappelli F, Lairez O, Munteanu C, Keohane D, Mallaina P May 21, 2022 HFA 2022 Transthyretin Amyloidosis (ATTR)
Poster
Witteles R, Sultan MB, Gundapaneni B, Garcia-Pavia P August 26, 2022 ESC 2022 Transthyretin Amyloidosis (ATTR)
Poster
Gonzalez-Moreno J, Dispenzieri A, Grogan M, Coelho T, Tournev I, Waddington-Cruz M, Wixner J, Diemberger I, Garcia Pavia P, Chapman D, Glass O, Amass L September 5, 2022 ISA 2022 Transthyretin Amyloidosis (ATTR)
Oral Presentation
Witteles R, Sultan MB, Gundapaneni B, Garcia-Pavia P September 5, 2022 ISA 2022 Transthyretin Amyloidosis (ATTR)
Poster
Waddington Cruz M, Planté-Bordeneuve V, Inamo J, Kristen A, Chapman D, Glass O, Amass L September 5, 2022 ISA 2022 Transthyretin Amyloidosis (ATTR)